P53 expression correlates with low axillary tumor burden in breast cancer
CONCLUSION: p53+ breast cancers were associated with worse overall survival. However, low ATB was more common in these tumors than in p53- tumors in the luminal B-Her2-negative subtype. Information on p53 expression could be of use to predict ATB in some breast cancer tumors.PMID:38143332 | DOI:10.3233/BD-230013 (Source: Breast Disease)
Source: Breast Disease - December 25, 2023 Category: Cancer & Oncology Authors: Pau Nicolau Paula Mas ó N úria Argudo Marta Jim énez Ana Isabel Mart ínez Ivonne V ázquez Laura Comerma Maria Vernet-Tom ás Source Type: research
Course of objectively measured physical activity and sleep in postmenopausal breast cancer survivors during the COVID-19 pandemic: A 1-year follow-up
CONCLUSIONS: Low levels of PA with mostly light intensity, and adequate sleep efficiency and duration were observed before COVID in PMBC survivors. This was not further affected by COVID-19 governmental measures.PMID:38143333 | DOI:10.3233/BD-230049 (Source: Breast Disease)
Source: Breast Disease - December 25, 2023 Category: Cancer & Oncology Authors: Sandra J M van Cappellen-van Maldegem Meeke Hoedjes Michiel R de Boer Inge L Nijman Henrike M W van Valenberg Jacob C Seidell Lonneke V van de Poll-Franse Laurien M Buffart Floortje Mols Belle H de Rooij Source Type: research
Expression and promoter methylation of mitogen-activated protein kinase 1 in tumor and marginal cells of breast cancer
CONCLUSION: Our findings suggest that while MAPK1 expression, might be a promising biomarker for evaluating oncogenic activity in patients suspected of BCa. We were not able to detect a prognostic/diagnostic role for MAPK1 promoter methylation.PMID:38143331 | DOI:10.3233/BD-230001 (Source: Breast Disease)
Source: Breast Disease - December 25, 2023 Category: Cancer & Oncology Authors: Solmaz Goldoost Habib Zarredar Milad Asadi Milad Shirvaliloo Mortaza Raeisi Source Type: research
P53 expression correlates with low axillary tumor burden in breast cancer
CONCLUSION: p53+ breast cancers were associated with worse overall survival. However, low ATB was more common in these tumors than in p53- tumors in the luminal B-Her2-negative subtype. Information on p53 expression could be of use to predict ATB in some breast cancer tumors.PMID:38143332 | DOI:10.3233/BD-230013 (Source: Breast Disease)
Source: Breast Disease - December 25, 2023 Category: Cancer & Oncology Authors: Pau Nicolau Paula Mas ó N úria Argudo Marta Jim énez Ana Isabel Mart ínez Ivonne V ázquez Laura Comerma Maria Vernet-Tom ás Source Type: research
Course of objectively measured physical activity and sleep in postmenopausal breast cancer survivors during the COVID-19 pandemic: A 1-year follow-up
CONCLUSIONS: Low levels of PA with mostly light intensity, and adequate sleep efficiency and duration were observed before COVID in PMBC survivors. This was not further affected by COVID-19 governmental measures.PMID:38143333 | DOI:10.3233/BD-230049 (Source: Breast Disease)
Source: Breast Disease - December 25, 2023 Category: Cancer & Oncology Authors: Sandra J M van Cappellen-van Maldegem Meeke Hoedjes Michiel R de Boer Inge L Nijman Henrike M W van Valenberg Jacob C Seidell Lonneke V van de Poll-Franse Laurien M Buffart Floortje Mols Belle H de Rooij Source Type: research
Expression and promoter methylation of mitogen-activated protein kinase 1 in tumor and marginal cells of breast cancer
CONCLUSION: Our findings suggest that while MAPK1 expression, might be a promising biomarker for evaluating oncogenic activity in patients suspected of BCa. We were not able to detect a prognostic/diagnostic role for MAPK1 promoter methylation.PMID:38143331 | DOI:10.3233/BD-230001 (Source: Breast Disease)
Source: Breast Disease - December 25, 2023 Category: Cancer & Oncology Authors: Solmaz Goldoost Habib Zarredar Milad Asadi Milad Shirvaliloo Mortaza Raeisi Source Type: research
P53 expression correlates with low axillary tumor burden in breast cancer
CONCLUSION: p53+ breast cancers were associated with worse overall survival. However, low ATB was more common in these tumors than in p53- tumors in the luminal B-Her2-negative subtype. Information on p53 expression could be of use to predict ATB in some breast cancer tumors.PMID:38143332 | DOI:10.3233/BD-230013 (Source: Breast Disease)
Source: Breast Disease - December 25, 2023 Category: Cancer & Oncology Authors: Pau Nicolau Paula Mas ó N úria Argudo Marta Jim énez Ana Isabel Mart ínez Ivonne V ázquez Laura Comerma Maria Vernet-Tom ás Source Type: research
Course of objectively measured physical activity and sleep in postmenopausal breast cancer survivors during the COVID-19 pandemic: A 1-year follow-up
CONCLUSIONS: Low levels of PA with mostly light intensity, and adequate sleep efficiency and duration were observed before COVID in PMBC survivors. This was not further affected by COVID-19 governmental measures.PMID:38143333 | DOI:10.3233/BD-230049 (Source: Breast Disease)
Source: Breast Disease - December 25, 2023 Category: Cancer & Oncology Authors: Sandra J M van Cappellen-van Maldegem Meeke Hoedjes Michiel R de Boer Inge L Nijman Henrike M W van Valenberg Jacob C Seidell Lonneke V van de Poll-Franse Laurien M Buffart Floortje Mols Belle H de Rooij Source Type: research
Expression and promoter methylation of mitogen-activated protein kinase 1 in tumor and marginal cells of breast cancer
CONCLUSION: Our findings suggest that while MAPK1 expression, might be a promising biomarker for evaluating oncogenic activity in patients suspected of BCa. We were not able to detect a prognostic/diagnostic role for MAPK1 promoter methylation.PMID:38143331 | DOI:10.3233/BD-230001 (Source: Breast Disease)
Source: Breast Disease - December 25, 2023 Category: Cancer & Oncology Authors: Solmaz Goldoost Habib Zarredar Milad Asadi Milad Shirvaliloo Mortaza Raeisi Source Type: research
P53 expression correlates with low axillary tumor burden in breast cancer
CONCLUSION: p53+ breast cancers were associated with worse overall survival. However, low ATB was more common in these tumors than in p53- tumors in the luminal B-Her2-negative subtype. Information on p53 expression could be of use to predict ATB in some breast cancer tumors.PMID:38143332 | DOI:10.3233/BD-230013 (Source: Breast Disease)
Source: Breast Disease - December 25, 2023 Category: Cancer & Oncology Authors: Pau Nicolau Paula Mas ó N úria Argudo Marta Jim énez Ana Isabel Mart ínez Ivonne V ázquez Laura Comerma Maria Vernet-Tom ás Source Type: research
Course of objectively measured physical activity and sleep in postmenopausal breast cancer survivors during the COVID-19 pandemic: A 1-year follow-up
CONCLUSIONS: Low levels of PA with mostly light intensity, and adequate sleep efficiency and duration were observed before COVID in PMBC survivors. This was not further affected by COVID-19 governmental measures.PMID:38143333 | DOI:10.3233/BD-230049 (Source: Breast Disease)
Source: Breast Disease - December 25, 2023 Category: Cancer & Oncology Authors: Sandra J M van Cappellen-van Maldegem Meeke Hoedjes Michiel R de Boer Inge L Nijman Henrike M W van Valenberg Jacob C Seidell Lonneke V van de Poll-Franse Laurien M Buffart Floortje Mols Belle H de Rooij Source Type: research
Expression and promoter methylation of mitogen-activated protein kinase 1 in tumor and marginal cells of breast cancer
CONCLUSION: Our findings suggest that while MAPK1 expression, might be a promising biomarker for evaluating oncogenic activity in patients suspected of BCa. We were not able to detect a prognostic/diagnostic role for MAPK1 promoter methylation.PMID:38143331 | DOI:10.3233/BD-230001 (Source: Breast Disease)
Source: Breast Disease - December 25, 2023 Category: Cancer & Oncology Authors: Solmaz Goldoost Habib Zarredar Milad Asadi Milad Shirvaliloo Mortaza Raeisi Source Type: research
P53 expression correlates with low axillary tumor burden in breast cancer
CONCLUSION: p53+ breast cancers were associated with worse overall survival. However, low ATB was more common in these tumors than in p53- tumors in the luminal B-Her2-negative subtype. Information on p53 expression could be of use to predict ATB in some breast cancer tumors.PMID:38143332 | DOI:10.3233/BD-230013 (Source: Breast Disease)
Source: Breast Disease - December 25, 2023 Category: Cancer & Oncology Authors: Pau Nicolau Paula Mas ó N úria Argudo Marta Jim énez Ana Isabel Mart ínez Ivonne V ázquez Laura Comerma Maria Vernet-Tom ás Source Type: research
Course of objectively measured physical activity and sleep in postmenopausal breast cancer survivors during the COVID-19 pandemic: A 1-year follow-up
CONCLUSIONS: Low levels of PA with mostly light intensity, and adequate sleep efficiency and duration were observed before COVID in PMBC survivors. This was not further affected by COVID-19 governmental measures.PMID:38143333 | DOI:10.3233/BD-230049 (Source: Breast Disease)
Source: Breast Disease - December 25, 2023 Category: Cancer & Oncology Authors: Sandra J M van Cappellen-van Maldegem Meeke Hoedjes Michiel R de Boer Inge L Nijman Henrike M W van Valenberg Jacob C Seidell Lonneke V van de Poll-Franse Laurien M Buffart Floortje Mols Belle H de Rooij Source Type: research
Expression and promoter methylation of mitogen-activated protein kinase 1 in tumor and marginal cells of breast cancer
CONCLUSION: Our findings suggest that while MAPK1 expression, might be a promising biomarker for evaluating oncogenic activity in patients suspected of BCa. We were not able to detect a prognostic/diagnostic role for MAPK1 promoter methylation.PMID:38143331 | DOI:10.3233/BD-230001 (Source: Breast Disease)
Source: Breast Disease - December 25, 2023 Category: Cancer & Oncology Authors: Solmaz Goldoost Habib Zarredar Milad Asadi Milad Shirvaliloo Mortaza Raeisi Source Type: research
